Common Contracts
13 similar Change-in-Control Agreement contracts by Invitrogen Corp
CHANGE-IN-CONTROL AGREEMENTChange-in-Control Agreement • March 2nd, 2007 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware
This CHANGE IN CONTROL AGREEMENT (“the Agreement”) by and between INVITROGEN CORPORATION, a Delaware Corporation (the “Company”), and [Name] (the “Executive”), dated as of the th Day of , 20 .
AMENDED AND RESTATED CHANGE-IN-CONTROL AGREEMENTChange-in-Control Agreement • March 2nd, 2007 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware
AGREEMENT by and between INVITROGEN CORPORATION, a Delaware Corporation (the “Company”), and Gregory T. Lucier (the “Executive”), dated as of the 28th day of February 2007.
CHANGE-IN-CONTROL AGREEMENTChange-in-Control Agreement • July 11th, 2005 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware
This CHANGE IN CONTROL AGREEMENT (“the Agreement”) by and between INVITROGEN CORPORATION, a Delaware Corporation (the “Company”), and Pete M. Leddy (the “Executive”), dated as of the July 5, 2005.
CHANGE-IN-CONTROL AGREEMENTChange-in-Control Agreement • October 18th, 2004 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware
This CHANGE IN CONTROL AGREEMENT (“the Agreement”) by and between INVITROGEN CORPORATION, a Delaware Corporation (the “Company”), and David F. Hoffmeister (the “Executive”), dated as of the 13th day of October 2004.
CHANGE-IN-CONTROL AGREEMENTChange-in-Control Agreement • May 10th, 2004 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware
This CHANGE IN CONTROL AGREEMENT (“the Agreement”) by and between INVITROGEN CORPORATION, a Delaware Corporation (the “Company”), and Nicholas Barthelemy (the “Executive”), dated as of the 10th day of March 2004.
CHANGE-IN-CONTROL AGREEMENTChange-in-Control Agreement • May 10th, 2004 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware
This CHANGE IN CONTROL AGREEMENT (“the Agreement”) by and between INVITROGEN CORPORATION, a Delaware Corporation (the “Company”), and Karen Gibson (the “Executive”), dated as of the 30th day of January, 2004.
AMENDED AND RESTATED CHANGE-IN-CONTROL AGREEMENTChange-in-Control Agreement • March 3rd, 2004 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware
This AMENDED AND RESTATED CHANGE IN CONTROL AGREEMENT (“the Agreement”) by and between INVITROGEN CORPORATION, a Delaware Corporation (the “Company”), and C. Eric Winzer (the “Executive”), dated as of the 16th day of October 2003.
CHANGE-IN-CONTROL AGREEMENTChange-in-Control Agreement • March 3rd, 2004 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware
This CHANGE IN CONTROL AGREEMENT (“the Agreement”) by and between INVITROGEN CORPORATION, a Delaware Corporation (the “Company”), and Claude D. Benchimol (the “Executive”), dated as of the 16th day of October 2003.
CHANGE-IN-CONTROL AGREEMENTChange-in-Control Agreement • March 3rd, 2004 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware
This CHANGE IN CONTROL AGREEMENT (“the Agreement”) by and between INVITROGEN CORPORATION, a Delaware Corporation (the “Company”), and Joe Rodriguez (the “Executive”), dated as of the 23rd day of October 2003.
AMENDED AND RESTATED CHANGE-IN-CONTROL AGREEMENTChange-in-Control Agreement • March 3rd, 2004 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware
This AMENDED AND RESTATED CHANGE IN CONTROL AGREEMENT (“the Agreement”) by and between INVITROGEN CORPORATION, a Delaware Corporation (the “Company”), and Daryl J. Faulkner (the “Executive”), dated as of the 16th day of October 2003.
AMENDED AND RESTATED CHANGE-IN-CONTROL AGREEMENTChange-in-Control Agreement • March 3rd, 2004 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware
This AMENDED AND RESTATED CHANGE IN CONTROL AGREEMENT (“the Agreement”) by and between INVITROGEN CORPORATION, a Delaware Corporation (the “Company”), and John D. Thompson (the “Executive”), dated as of the 16th day of October 2003.
CHANGE-IN-CONTROL AGREEMENTChange-in-Control Agreement • March 3rd, 2004 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware
This CHANGE IN CONTROL AGREEMENT (“the Agreement”) by and between INVITROGEN CORPORATION, a Delaware Corporation (the “Company”), and Benjamin Bulkley (the “Executive”), dated as of the 16th day of October 2003.
AMENDED AND RESTATED CHANGE-IN-CONTROL AGREEMENTChange-in-Control Agreement • March 3rd, 2004 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware
This AMENDED AND RESTATED CHANGE IN CONTROL AGREEMENT (“the Agreement”) by and between INVITROGEN CORPORATION, a Delaware Corporation (the “Company”), and John A. Cottingham (the “Executive”), dated as of the 16th day of October 2003.
